The Fund delivered a 4.60% return in Q3 2025, driven by strong stock selection. Click here to read the full report to explore ...

Allspring California Tax-Free Fund missed its target despite positive bond market growth this quarter. Read the complete ...

DEADLINE DAY: It’s been nearly 300 days since AG Pam Bondi announced the first phase of the release of the files surrounding the late convicted sex offender Jeffrey Epstein. Back then, Bondi offered a ...

By conventional measures, the 2020s have not been very good for the movies. At mid-decade, there’s the nagging sense that the pre-COVID years represented glory days that will never be recaptured.

For half a century now, Project Censored has been bringing these omissions to light, and while each story highlights a ...

Important state and national stories, market and business news, sports and entertainment, delivered in quick-hit fashion In Mississippi ...

Bipolar Disorder, Digital Phenotyping, Multimodal Learning, Face/Voice/Phone, Mood Classification, Relapse Prediction, T-SNE, Ablation Share and Cite: de Filippis, R. and Al Foysal, A. (2025) ...

Guselkumab has received approval for moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.1The decision is supported by the ...

Kamto Chukwureh tells SiliconRepublic.com about sim racing and why Ireland needs to do more to support esports.

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based ...

Whether they're looking for a seaside mansion, a corner office, or a penthouse apartment, wealthy Americans on the move tend ...

LBL-047 (DNTH212) is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B ...